Quanticate Announces Strategic Partnership with KPS Life
Quanticate has announced its strategic partnership with KPS Life, a US-based provider of FSP solutions focused on clinical operations and clinical monitoring oversight.
This partnership will enable Biotech and Pharma companies to receive biometric data services from Quanticate coupled with global resourcing solutions from KPS Life. Additionally, it allows both organizations to prove life-science companies with a solution that delivers high-quality data and embedded human capital solutions. The complementary services ensure that biopharma companies receive support for their clinical research projects.
Reference
Quanticate announces strategic partnership with KPS Life. (2023, May 31). Quanticate.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Optimizing Phase III Oncology Trial Recruitment with Data-Driven Insights
February 3rd 2025A pharmaceutical company aimed to launch a Phase III clinical trial for a new oncology drug, focusing on efficient and effective patient recruitment across diverse regions. They evaluated patient populations by analyzing demographics, social determinants of health, and geography. Investigator profiling included practice details, affiliations, referral networks, and clinical trial experience. The final step involved selecting and extracting target lists for implementation.
